References
- World Health Organization Department of Reproductive Health and Research. Clinical practice handbook for safe abortion. Geneva: WHO; 2014.
- Constitution of the Socialist Federal Republic of Yugoslavia [in Slovenian]. Official Gazette of the Socialist Federal Republic of Yugoslavia, no. 9/74.
- Health Measures in Exercising Freedom of Choice in Childbearing Act [in Slovenian]. Official Gazette of the Socialist Republic of Slovenia, no. 11/1977, 42/1986 and 70/00.
- Pinter B. Medico-legal aspects of abortion in Europe. Eur J Contracept Reprod Health Care. 2002;7:15–19.
- Pinter B, Aubeny E, Bartfai G, et al. Accessibility and availability of abortion in six European countries. Eur J Contracept Reprod Health Care. 2005;10:51–58.
- Joffe C. Abortion in historical perspective. In: Paul M, Lichtenberg ES, Borgatta L, et al., editors. A clinician's guide to medical and surgical abortion. Edinburgh: Churchill Livingstone; 1998. p. 3–10.
- Aubeny E. Methods of abortion in Europe during the first trimester of pregnancy. Eur J Contracept Reprod Health Care. 1997;2:75–80.
- Fiala C, Gemzell-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception. 2006;74:66–86.
- Hamoda H, Templeton A. Medical and surgical options for induced abortion in first trimester. Best Pract Res Clin Obstet Gynaecol. 2010;24:503–516.
- Pinter B, Pretnar DA, Vogler A, et al. Contemporary aspects of termination of pregnancy. In: Takac I, et al., eds. 50 years of family planning in Maribor: international scientific symposium [in Slovenian]. Maribor: University Medical Centre 2007; 299–311.
- Štolfa GA, Abortion in the first trimester. In: Tul MN, Štolfa GA, editors. Medical abortion, proceedings [in Slovenian]. Ljubljana: Association for Perinatal Medicine; 2012. p. 31–42.
- National Institute of Public Health: Data portal. Ljubljana: National Institute of Public Health; 2018. [cited 2018 April 10]. Available from: https://podatki.nijz.si.
- Macisaac L, Darney P. Early surgical abortion: an alternative to and backup for medical abortion. Am J Obstet Gynecol. 2000;183:S76–S83.
- Keder LM. Best practices in surgical abortion. Am J Obstet Gynecol. 2003;189:418–422.
- Kara F, Dogan NU, Bati S, et al. Early surgical abortion: safe and effective. Eur J Contracept Reprod Health Care. 2013;18:120–126.
- Moreau C, Trussell J, Desfreres J, et al. Medical vs. surgical abortion: the importance of women's choice. Contraception. 2011;84:224–229.
- Flett GM, Templeton A. Surgical abortion. Best Pract Res Clin Obstet Gynaecol. 2002;16:247–261.
- Rademakers J, Koster E, Jansen-van Hees AC, et al. Medical abortion as an alternative to vacuum aspiration: first experiences with the 'abortion pill' in the Netherlands. Eur J Contracept Reprod Health Care. 2001;6:185–191.
- Berer M. Medical abortion: issues of choice and acceptability. Reprod Health Matters. 2005;13:25–34.
- Louie KS, Tsereteli T, Chong E, et al. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan. Eur J Contracept Reprod Health Care. 2014;19:457–464.
- Winikoff B, Sivin I, Coyaji KJ, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol. 1997;176:431–437.
- Ličer Z, Report of the social counselling service work in 2015 [in Slovenian]. Ljubljana: Gynaecology Clinic, University Medical Centre; 2016.
- Kopp Kallner H, Fiala C, Gemzell-Danielsson K. Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion. Contraception. 2012;85:394–397.
- Raghavan S, Maistruk G, Shochet T, et al. Efficacy and acceptability of early mifepristone–misoprostol medical abortion in Ukraine: results of two clinical trials. Eur J Contracept Reprod Health Care. 2013;18:112–119.
- Cavet S, Fiala C, Scemama A, et al. Assessment of pain during medical abortion with home use of misoprostol. Eur J Contracept Reprod Health Care. 2017;22:207–211.
- Royal College of Obstetricians and Gynaecologists. 2018. RCOG and FSRH statement on women in England being able to take misoprostol at home. [cited 2019 January12]. Available from: www.rcog.org.uk/en/news/rcog-and-fsrh-statement-on-women-in-england-being-able-to-take-misoprostol-at-home.
- Loeber OE, Muntinga ME. Contraceptive counselling for women with multiple unintended pregnancies: the abortion client's perspective. Eur J Contracept Reprod Health Care. 2017;22:94–101.
- Leeners B, Bieli S, Huang D, et al. Why prevention of repeat abortion is so challenging: psychosocial characteristics of women at risk. Eur J Contracept Reprod Health Care. 2017;22:38–44.
- Nielsen TC, Michel KG, White R, et al. Predictors of more effective contraceptive method use at 12 weeks post-abortion: a prospective cohort study. J Women’s Health. 2019;28:591–599.
- Pohjoranta E, Suhonen S, Mentula M, et al. Intrauterine contraception after medical abortion: factors affecting success of early insertion. Contraception. 2017;95:257–262.
- Loeber OE. Motivation and satisfaction with early medical vs. surgical abortion in the Netherlands. Reprod Health Matters. 2010;18:145–153.
- Pena M, Dzuba IG, Smith PS, et al. Efficacy and acceptability of a mifepristone–misoprostol combined regimen for early induced abortion among women in Mexico City. Int J Gynaecol Obstet. 2014;127:82–85.
- Ireland LD, Gatter M, Chen AY. Medical compared with surgical abortion for effective pregnancy termination in the first trimester. Obstet Gynecol. 2015;126:22–28.
- Tsereteli T, Chong E, Louie K, et al. Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia. Eur J Contracept Reprod Health Care. 2016;21:367–371.
- Tamang A, Shah IH, Shrestha P, et al. Comparative satisfaction of receiving medical abortion service from nurses and auxiliary nurse-midwives or doctors in Nepal: results of a randomized trial. Reprod Health. 2017;14:176.
- Jensen JT, Harvey SM, Beckman LJ. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Am J Obstet Gynecol. 2000;182:1292–1299.
- Woldetsadik MA, Sendekie TY, White MT, et al. Client preferences and acceptability for medical abortion and MVA as early pregnancy termination method in northwest Ethiopia. Reprod Health. 2011;8:19.
- Newton D, Bayly C, McNamee K, et al. How do women seeking abortion choose between surgical and medical abortion? Perspectives from abortion service providers. Aust N Z J Obstet Gynaecol. 2016;56:523–529.
- Fiala C, Cameron S, Bombas T, et al. Pain during medical abortion, the impact of the regimen: a neglected issue? A review. Eur J Contracept Reprod Health Care. 2014;19:404–419.
- Bracken H, Gliozheni O, Kati K, et al. Mifepristone medical abortion in Albania: results from a pilot clinical research study. Eur J Contracept Reprod Health Care. 2006;11:38–46.
- Beja V, Leal I. Abortion counselling according to healthcare providers: a qualitative study in the Lisbon metropolitan area, Portugal. Eur J Contracept Reprod Health Care. 2010;15:326–335.
- Vandamme J, Wyverkens E, Buysse A, et al. Pre-abortion counselling from women's point of view. Eur J Contracept Reprod Health Care. 2013;18:309–318.
- Turk JK, Preskill F, Landy U, et al. Availability and characteristics of abortion training in US ob-gyn residency programs: a national survey. Contraception. 2014;89:271–277.
- Liauw J, Dineley B, Gerster K, et al. Abortion training in Canadian obstetrics and gynecology residency programs. Contraception. 2016;94:478–482.